Peter J Barris has bought stock on 28 days since Jan 2016
Director at Groupon, Inc., and 16 other companies
SEC CIK 0001005561 · Filings on SEC.gov ↗
Peter J Barris's record
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Companies
- GRPN Groupon, Inc.Director
- TRVI Trevi Therapeutics, Inc.10% owner
- RGLS Regulus Therapeutics Inc.10% owner
- AVEO Aveo Pharmaceuticals, Inc.10% owner
- ADAP Adaptimmune Therapeutics Plc10% owner
- GLYC Glycomimetics Inc10% owner
- SURF Surface Oncology, Inc.10% owner
- TCON Tracon Pharmaceuticals, Inc.10% owner
- TSRO Tesaro, Inc.10% owner
- ABIO Arca Biopharma, Inc.10% owner
- SENS Senseonics Holdings, Inc.10% owner
- APPN Appian Corporation10% owner
- RYTM Rhythm Pharmaceuticals, Inc.10% owner
- MRSN Mersana Therapeutics, Inc.10% owner
- ILIU Interleukin Genetics Inc10% owner
- ARDX Ardelyx, Inc.10% owner
- EPZM Epizyme, Inc.10% owner
Every filing
40 filings since Jan 2016, newest first
Groupon, Inc.
Director
Trevi Therapeutics, Inc.
10% owner
Regulus Therapeutics Inc.
10% owner
Aveo Pharmaceuticals Inc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Adaptimmune Therapeutics Plc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Glycomimetics Inc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Surface Oncology, Inc.
10% owner
Aveo Pharmaceuticals Inc
10% owner
Adaptimmune Therapeutics Plc
10% owner
Tracon Pharmaceuticals, Inc.
10% owner
Adaptimmune Therapeutics Plc
10% owner
Tesaro, Inc.
10% owner
Arca Biopharma, Inc.
10% owner
Senseonics Holdings, Inc.
10% owner
Appian Corp
10% owner
Appian Corp
10% owner
Rhythm Pharmaceuticals, Inc.
10% owner
Groupon, Inc.
Director
Mersana Therapeutics, Inc.
10% owner
Groupon, Inc.
Director
Senseonics Holdings, Inc.
10% owner
Aveo Pharmaceuticals Inc
10% owner
Adaptimmune Therapeutics Plc
10% owner
Groupon, Inc.
Director
Groupon, Inc.
Director
Groupon, Inc.
Director
Interleukin Genetics Inc
10% owner
Ardelyx, Inc.
10% owner
Groupon, Inc.
Director
Ardelyx, Inc.
10% owner
Epizyme, Inc.
10% owner
About Peter J Barris
Peter J. Barris is an American venture capitalist and corporate director who serves as a director of Groupon, Inc. (GRPN) and has been a long‑time board member and early investor in the company.( A managing general partner and later chairman of New Enterprise Associates (NEA), one of the world’s largest venture capital firms, Barris joined NEA in 1992, specialized in information technology investments, and helped guide successful investments in companies such as Groupon, Salesforce, WebMD, Workday, CareerBuilder, Juniper Networks, and TiVo.( He has been repeatedly recognized on the Forbes Midas List of top technology investors and has served on numerous public and private boards, including Sprout Social, Echo Global Logistics, InnerWorkings, Vonage, and others.(
Before his venture capital career, Barris held senior operating roles, including President and COO of Legent Corporation and Senior Vice President of the Systems Software Division at UCCEL Corporation, after nearly a decade in management positions at General Electric, where he ultimately served as Vice President and General Manager at GE Information Services.( In addition to his corporate roles, he has been deeply involved in governance and philanthropy, serving as Chair (formerly Vice Chair) of the Board of Trustees of Northwestern University and on boards or advisory bodies for the Tuck School of Business at Dartmouth, the Brookings Institution, P33, and In‑Q‑Tel.( Barris holds a B.S. in Electrical Engineering from Northwestern University and an MBA from the Tuck School of Business at Dartmouth College.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.